Connect with us

Tampa biotech changes its name

May 28, 2019 - HedgePath Pharmaceuticals, a Tampa biotech working on cancer treatments, is changing its name to  Inhibitor Therapeutics Inc. The new name reflects the company’s broader mission, a filing with the Securities and Exchange Commission said. The company, which trades over-the-counter, will change its ticker from HPPI to INTI. It also plans a reverse stock split, and said the move should increase the stock price so it can trade on the Nasdaq Capital Market or NYSE American exchange.

More Zaps Frontpage

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us: spark@stpetecatalyst.com

Subscribe for Free

Share with friend

Enter the details of the person you want to share this article with.